MedTrace Logo

Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.

NCT00184288 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2011-11-02

No results posted yet for this study

Summary

The aim of the study is to investigate the feasibility of in vivo single volume MR spectroscopy in evaluation of treatment response in patients with brain metastases, using 3T MR instrument. In order to optimize and avoid ineffective treatment of patients with brain metastases, in vivo MR spectroscopy can be an useful tool.

Conditions

  • Neoplasm Metastasis
  • Lung Neoplasms
  • Breast Neoplasms
  • Melanoma

Sponsors & Collaborators

  • The Royal Norwegian Ministry of Health

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Steinar Lundgren, MD PhD · Cancer clinic, St.Olavs Hospital Trondheim University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Primary Completion
2006-06-30
Completion
2010-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00184288 on ClinicalTrials.gov